Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.4.389

Noni Inhibits Neuronal Damage Caused by the Immune Reaction of Microglial Cells Activated by Doxorubicin  

Jung, Se-Hwa (Department of Biomedical Laboratory Science, Konyang University)
Lee, Seong-Min (Department of Biomedical Laboratory Science, Konyang University)
Ha, Ji-Sun (Department of Biomedical Laboratory Science, Konyang University)
Yang, Seung-Ju (Department of Biomedical Laboratory Science, Konyang University)
Kim, Pyung-Hwan (Department of Biomedical Laboratory Science, Konyang University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.4, 2020 , pp. 389-397 More about this Journal
Abstract
Microglial cells function as major immune cells in the brain, playing an important role in the protection and damage of neurons. BV2 microglia, activated by drug stimulation, secrete inflammatory cytokines by activating the nuclear factor kappa-light-chain-enhancer of the activated B cells pathway and are involved in neuroinflammatory and immune responses. The overactivation of microglia by stimuli can cause neuronal damage, leading to brain disease. Noni, a natural product, reduces the activity of microglia to prevent neuronal damage and is a potential natural medicine because it exerts excellent regeneration and anti-inflammatory effects on damaged cells. In this study, when noni was used to treat BV2 cells stimulated by the anti-cancer drug doxorubicin, it reduced the release of pro-inflammatory cytokines from BV2. On the other hand, neuronal damage is a side effect of doxorubicin. Therefore, the cytokines released from doxorubicin-stimulated BV2 cells treated with noni had a positive effect on the neuronal viability compared to those released from doxorubicin-stimulated BV2 cells not treated with Noni. Thus, Noni increases neuronal viability. These results suggest that noni inhibits the release of cytokines by regulating the nuclear factor kappa-light-chain-enhancer of the activated B cells pathway of BV2, thereby inhibiting neuronal damage.
Keywords
Activated BV-2 microglia; Doxorubicin; Neuron; Noni;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 de Simone V, Franze E, Ronchetti G, Colantoni A, Fantini MC, di Fusco D, et al. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015;34:3493-3503. https://doi.org/10.1038/onc.2014.286   DOI
2 El-Agamy SE, Abdel-Aziz AK, Wahdan S, Esmat A, Azab SS. Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries. J Mol Neurosci. 2018;55:5727-5740. https://doi.org/10.1007/s12035-017-0797-7   DOI
3 Hurmach Y, Rudyk M, Prylutska S, Hurmach V, Prylutskyy YI, Ritter U, et al. C60 fullerene governs doxorubicin effect on metabolic profile of rat microglial cells in vitro. Mol Pharm. 2020;17:3622-3632. https://doi.org/10.1021/acs.molpharmaceut.0c00691   DOI
4 Marques L, Johnson AA, Stolzing A. Doxorubicin generates senescent microglia that exhibit altered proteomes, higher levels of cytokine secretion, and a decreased ability to internalize amyloid β. Exp Cell Res. 2020;395:112203. https://doi.org/10.1016/j.yexcr.2020.112203   DOI
5 Mohamed RH, Karam RA, Amer MG. Epicatechin attenuates doxorubicin-induced brain toxicity: Critical role of TNF-α, iNOS and NF-κB. Brain Res Bull. 2011;86:22-28. https://doi.org/10.1016/j.brainresbull.2011.07.001   DOI
6 Wood PL. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res. 1995;17:242-248. https://doi.org/10.1080/01616412.1995.11740321   DOI
7 Lee S, Kim DC, Baek HY, Lee KD, Kim YC, Oh H. Anti-neuroinflammatory effects of tryptanthrin from polygonum tinctorium Lour. in lipopolysaccharide-stimulated BV2 microglial cells. Arch pharm. 2018;41:419-430. https://doi.org/10.1007/s12272-018-1020-8   DOI
8 Pandur E, Varga E, Tamási K, Pap R, Nagy J, Sipos K. Effect of inflammatory mediators lipopolysaccharide and lipoteichoic acid on iron metabolism of differentiated SH-SY5Y cells alters in the presence of BV-2 microglia. Int J Mol Sci. 2019;20:17. https://doi.org/10.3390/ijms20010017   DOI
9 Kwon YW, Cheon SY, Park SY, Song J, Lee JH. Tryptanthrin suppresses the activation of the LPS-treated BV2 microglial cell line via Nrf2/HO-1 antioxidant signaling. Front Cell Neurosci. 2017;11:18. https://doi.org/10.3389/fncel.2017.00018   DOI
10 Guo C, Yang L, Wan CX, Xia YZ, Zhang C, Chen MH, et al. Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways. Phytomedicine. 2016;23:1629-37. https://doi.org/10.1016/j.phymed.2016.10.007   DOI
11 Xu Z, Nan W, Zhang X, Sun YS, Yang J, Lu K, et al. Umbilical cord mesenchymal stem cells conditioned medium promotes Aβ25-35 phagocytosis by modulating autophagy and aβ-degrading enzymes in BV2 cells. J Mol Neurosci. 2018;65:222-233. https://doi.org/10.1007/s12031-018-1075-5   DOI
12 Gupta RK, Banerjee A, Pathak S, Sharma C, Singh N. Induction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells. Asian Pac J Cancer Prev. 2013;14:237-42. https://doi.org/10.7314/apjcp.2013.14.1.237   DOI
13 Hamblin C, Barnett I, Hedger R. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. Development and method of ELISA. J Immunol Methods. 1986;93:115-121. https://doi.org/10.1016/0022-1759(86)90442-4   DOI
14 Loizou S, McCrea J, Rudge A, Reynolds R, Boyle C, Harris E. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol. 1985;62:738.
15 West M, Hackam DJ, Baker J, Rodriquez JL, Bellingham J, Rotstein OD. Mechanism of decreased in vitro murine macrophage cytokine release after exposure to carbon dioxide: Relevance to laparoscopic surgery. Ann Surg. 1997;226:179-190. https://doi.org/10.1097/00000658-199708000-00010   DOI
16 Wang MY, Su C. Cancer preventive effect of Morinda citrifolia (Noni). Ann NY Acad Sci. 2001;952:161-168.   DOI
17 Park HY, Kim GY, Choi YH. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol. 2012;30:204-210. https://doi.org/10.3892/ijmm.2012.979   DOI
18 Bramorski A, Cherem AdR, Marmentini CP, Torresani J, Mezadri T, Costa AdAS. Total polyphenol content and antioxidant activity of commercial Noni (Morinda citrifolia L.) juice and its components. Braz J Pharm Sci. 2010;46:651-656. https://doi.org/10.1590/s1984-82502010000400006   DOI
19 de Sousa BC, Miguel CB, Rodrigues WF, Machado JR, da Silva MV, da Costa TA, et al. Effects of short-term consumption of Morinda citrifolia (Noni) fruit juice on mice intestine, liver and kidney immune modulation. Food Agric Immunol. 2017;28:528-542. https://doi.org/10.1080/09540105.2017.1306492   DOI
20 Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK, et al. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin. 2002;23:1127-41.
21 Yang J, Gadi R, Paulino R, Thomson T. Total phenolics, ascorbic acid, and antioxidant capacity of noni (Morinda citrifolia L.) juice and powder as affected by illumination during storage. Food Chem. 2010;122:627-632. https://doi.org/10.1016/j.foodchem.2010.03.022   DOI
22 Lu J, Li J, Hu Y, Guo Z, Sun D, Wang P, et al. Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation. Acta Pharm Sin B. 2019;9:782-793. https://doi.org/10.1016/j.apsb.2018.10.008   DOI
23 Bigotte L, Olsson Y. Degeneration of trigeminal ganglion neurons caused by retrograde axonal transport of doxorubicin. Neurol. 1987;37:985. https://doi.org/10.1212/wnl.37.6.985   DOI
24 Mori H, Nakamachi T, Ohtaki H, Yofu S, Sato A, Endo K, et al. Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ J. 2010;74:1183-1190. https://doi.org/10.1253/circj.cj-09-1024   DOI
25 Lee JW, Cheong IY, Kim HS, Lee JJ, Lee YS, Kwon YS, et al. Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial Cells. Korean J Physiol Pharmacol. 2011;15:9-15. https://doi.org/10.4196/kjpp.2011.15.1.9   DOI